ConductScience.org, home
Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted
API referenceFor AI assistants

Trial · NCT03832114

Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Run-in PhaseSTARTEDCohort A: Run-In Phase16
Run-in PhaseSTARTEDCohort B: Run-In Phase11
Run-in PhaseSTARTEDCohort A: Dose Escalation/LNP023 Treatment 200 mg b.i.d0
Run-in PhaseSTARTEDCohort B - Dose Escalation/LNP023 Treatment 200 mg b.i.d0
Run-in PhaseCOMPLETEDCohort A: Run-In Phase16
Run-in PhaseCOMPLETEDCohort B: Run-In Phase11
Run-in PhaseCOMPLETEDCohort A: Dose Escalation/LNP023 Treatment 200 mg b.i.d0
Run-in PhaseCOMPLETEDCohort B - Dose Escalation/LNP023 Treatment 200 mg b.i.d0
Run-in PhaseNOT COMPLETEDCohort A: Run-In Phase0
Run-in PhaseNOT COMPLETEDCohort B: Run-In Phase0
Run-in PhaseNOT COMPLETEDCohort A: Dose Escalation/LNP023 Treatment 200 mg b.i.d0
Run-in PhaseNOT COMPLETEDCohort B - Dose Escalation/LNP023 Treatment 200 mg b.i.d0
Dose Escalation/200mg b.i.d TreatmentSTARTEDCohort A: Run-In Phase0
Dose Escalation/200mg b.i.d TreatmentSTARTEDCohort B: Run-In Phase0
Dose Escalation/200mg b.i.d TreatmentSTARTEDCohort A: Dose Escalation/LNP023 Treatment 200 mg b.i.d16
Dose Escalation/200mg b.i.d TreatmentSTARTEDCohort B - Dose Escalation/LNP023 Treatment 200 mg b.i.d11
Dose Escalation/200mg b.i.d TreatmentCOMPLETEDCohort A: Run-In Phase0
Dose Escalation/200mg b.i.d TreatmentCOMPLETEDCohort B: Run-In Phase0
Dose Escalation/200mg b.i.d TreatmentCOMPLETEDCohort A: Dose Escalation/LNP023 Treatment 200 mg b.i.d16
Dose Escalation/200mg b.i.d TreatmentCOMPLETEDCohort B - Dose Escalation/LNP023 Treatment 200 mg b.i.d11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03832114/flow

API referenceFor AI assistants